Epstein‐Barr Virus Expressed Long Non‐Coding RNA ( lncBART s) Regulate EBV Latent Genome Replication
Advanced Science · 2026
DOI: 10.1002/advs.202507286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jiayan Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Emerging Infectious Diseases and Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, RNA, Long Noncoding, Virus Replication, Virus Latency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Research Fund, Health@InnoHK, ITC funding support to State Key Laboratory for Emerging Infectious Diseases.
Abstract (Originalsprache)
Epstein‐Barr virus (EBV) is a ubiquitous human virus that is also linked to various human cancers. In EBV‐associated nasopharyngeal carcinoma and gastric carcinoma cells, EBV expresses only essential viral antigens but high levels of long non‐coding RNAs known as BamHI‐A rightward transcripts ( lncBART s). The exact roles lncBART s in the EBV life cycle and the development of EBV‐associated cancers are largely not understood. This study demonstrates that lncBART s play a role in maintaining viral genome replication by affecting the tethering of EBV ori P region to chromosome. Mechanistically, lncBART s interact functionally with a complex consisting of Bromodomain‐containing protein 4 (BRD4), CCTC‐binding factor (CTCF), and EBV nuclear antigen 1 (EBNA1), anchoring their binding at ori P to facilitate EBV episome replication. Additionally, the lncBART s‐BRD4/CTCF complex contributes to the regulation of MYC and BCL2 expression. These findings suggest that lncBART s modulate EBV latency through interactions with ori P region, while lncBART s‐BRD4/CTCF complexes promote host epigenome reprogramming and drive tumorigenesis in EBV‐associated epithelial tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Emerging Infectious Diseases and Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
- Centre for Virology, Vaccinology and Therapeutics Limited, Hong Kong SAR, China.
- Department of Clinical Oncology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
- Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China.
- Cancer Research Institute of Zhongshan City, Zhongshan People's Hospital, Zhongshan, Guangdong, China.
ORCID-Profile: Jiayan Liu, Wei Dai, Honglin Chen
Förderung
- General Research Fund
- Health@InnoHK
- ITC funding support to State Key Laboratory for Emerging Infectious Diseases
Zitieren
APA
Liu, J., Chung, D. L., Chow, L. K., Han, S., Yi, W., Cremin, C. J., Liao, Y., Wang, P., Mok, B. W., Ji, M., Yan, J., Dai, W., & Chen, H. (2026). Epstein‐Barr Virus Expressed Long Non‐Coding RNA ( lncBART s) Regulate EBV Latent Genome Replication. Advanced Science. https://doi.org/10.1002/advs.202507286
Vancouver
Liu J, Chung DL, Chow LK, Han S, Yi W, Cremin CJ, et al. Epstein‐Barr Virus Expressed Long Non‐Coding RNA ( lncBART s) Regulate EBV Latent Genome Replication. Advanced Science. 2026. doi:10.1002/advs.202507286
BibTeX
@article{Liu2026,
author = {Liu, Jiayan and Chung, Dittman Lai-Shun and Chow, Larry Ka-Yue and Han, Shuo and Yi, Wenkai and Cremin, Conor J and Liao, Yingyin and Wang, Pui and Mok, Bobo Wing-Yee and Ji, Mingfang and Yan, Jian and Dai, Wei and Chen, Honglin},
title = {Epstein‐Barr Virus Expressed Long Non‐Coding RNA ( lncBART s) Regulate EBV Latent Genome Replication},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202507286}
}
EUVIMED